Europe Immunoassays in R&D market By Product & Services

Eastern-europe accounted for the largest market share in 2017 in the europe immunoassays in r&d market, and is expected to reach usd 469.50 million in 2023 from usd 290.40 million in 2017. however, united kingdom is the fastest growing market, which is expected to grow at a cagr of 8.51% during the forecast period 2018 - 2023. pharmaceutical and biotechnology companies segment accounted for the largest market share in 2017, this market is expected to reach usd 1148.90 million in 2023 from usd 737.90 million in 2017. this market is projected to grow at a cagr of 7.20% during the forecast period from 2018 - 2023. however, academic institutions and laboratories segment is the fastest growing market, which is expected to grow at a cagr of 8.38% during the forecast period 2018 - 2023. elisa segment accounted for the largest market share in 2017, this market is expected to reach usd 759.50 million in 2023 from usd 495.90 million in 2017. this market is projected to grow at a cagr of 6.83% during the forecast period from 2018 - 2023. however, enzyme linked immunospot assay elispot segment is the fastest growing market, which is expected to grow at a cagr of 9.77% during the forecast period 2018 - 2023. kits and reagents segment accounted for the largest market share in 2017, this market is expected to reach usd 1128.80 million in 2023 from usd 692.20 million in 2017. this market is projected to grow at a cagr of 8.28% during the forecast period from 2018 - 2023. however, kits and reagents segment is the fastest growing market, which is expected to grow at a cagr of 8.28% during the forecast period 2018 - 2023. endocrinology segment accounted for the largest market share in 2017, this market is expected to reach usd 831.20 million in 2023 from usd 486.60 million in 2017. this market is projected to grow at a cagr of 9.31% during the forecast period from 2018 - 2023. however, endocrinology segment is the fastest growing market, which is expected to grow at a cagr of 9.31% during the forecast period 2018 - 2023.